Ford Motor Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Ford Motor Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
---|---|---|---|---|---|
first half | |||||
cash flows from operating activities | |||||
net income/ | 1,831,000,000 | -523,000,000 | 1,259,000,000 | 12,273,000,000 | -2,791,000,000 |
depreciation and tooling amortization | 1,931,000,000 | 2,012,000,000 | 1,973,000,000 | 1,840,000,000 | 2,081,000,000 |
other amortization | -481,000,000 | -314,000,000 | -273,000,000 | -324,000,000 | -356,000,000 |
benefit from credit and insurance losses | 142,000,000 | 63,000,000 | |||
pension and other postretirement employee benefits | -540,000,000 | 2,026,000,000 | |||
equity method investment (earnings)/losses and impairments in excess of dividends received | |||||
foreign currency adjustments | -69,000,000 | -135,000,000 | 44,000,000 | 184,000,000 | -204,000,000 |
net realized and unrealized | 17,000,000 | 18,000,000 | 153,000,000 | ||
stock compensation | 107,000,000 | 110,000,000 | 59,000,000 | 43,000,000 | 29,000,000 |
benefit from/(benefit from) deferred income taxes | 679,000,000 | -1,604,000,000 | |||
decrease/ | -1,560,000,000 | -3,593,000,000 | -3,959,000,000 | -852,000,000 | 1,098,000,000 |
decrease/(increase) in accounts receivable and other assets | -451,000,000 | 345,000,000 | 1,187,000,000 | 188,000,000 | -137,000,000 |
decrease/(increase) in inventory | 2,365,000,000 | 3,010,000,000 | 1,584,000,000 | 1,351,000,000 | 350,000,000 |
increase/(decrease) in accounts payable and accrued and other liabilities | -961,000,000 | 634,000,000 | -1,185,000,000 | 475,000,000 | 2,951,000,000 |
other | 89,000,000 | 369,000,000 | 79,000,000 | -158,000,000 | 25,000,000 |
net cash provided by/(used in) operating activities | 3,028,000,000 | 2,492,000,000 | 1,178,000,000 | 3,531,000,000 | 4,539,000,000 |
cash flows from investing activities | |||||
capital spending | -2,498,000,000 | -2,295,000,000 | -2,065,000,000 | -1,772,000,000 | -1,531,000,000 |
acquisitions of finance receivables and operating leases | -14,778,000,000 | -14,343,000,000 | -12,545,000,000 | -13,686,000,000 | -12,428,000,000 |
collections of finance receivables and operating leases | 11,304,000,000 | 10,835,000,000 | 10,600,000,000 | 12,654,000,000 | 12,210,000,000 |
purchases of marketable securities and other investments | -3,799,000,000 | -2,691,000,000 | -3,343,000,000 | -4,248,000,000 | -12,223,000,000 |
sales and maturities of marketable securities and other investments | 1,735,000,000 | 2,316,000,000 | 2,909,000,000 | 4,790,000,000 | 7,993,000,000 |
settlements of derivatives | -94,000,000 | 69,000,000 | -139,000,000 | -28,000,000 | 84,000,000 |
capital contributions to equity method investments | -123,000,000 | -1,118,000,000 | |||
returns of capital from equity method investments | |||||
net cash provided by/(used in) investing activities | -6,861,000,000 | -7,409,000,000 | -4,972,000,000 | -2,263,000,000 | -5,745,000,000 |
cash flows from financing activities | |||||
cash payments for dividends and dividend equivalents | -596,000,000 | -601,000,000 | -599,000,000 | -400,000,000 | 0 |
purchases of common stock | -150,000,000 | ||||
net changes in short-term debt | 957,000,000 | -597,000,000 | 3,810,000,000 | 1,705,000,000 | 524,000,000 |
proceeds from issuance of long-term debt | 13,733,000,000 | 15,077,000,000 | 12,615,000,000 | 8,601,000,000 | 11,575,000,000 |
payments of long-term debt | -10,117,000,000 | -10,146,000,000 | -8,260,000,000 | ||
net cash provided by/(used in) financing activities | 3,790,000,000 | 3,383,000,000 | 7,055,000,000 | -8,078,000,000 | 2,284,000,000 |
effect of exchange rate changes on cash, cash equivalents, and restricted cash | -493,000,000 | 10,000,000 | 358,000,000 | -77,000,000 | 385,000,000 |
net increase/(decrease) in cash, cash equivalents, and restricted cash | -536,000,000 | -1,524,000,000 | 3,619,000,000 | -6,887,000,000 | 1,463,000,000 |
cash, cash equivalents, and restricted cash at beginning of period | 0 | 0 | 0 | 0 | 0 |
cash, cash equivalents, and restricted cash at end of period | -536,000,000 | -1,524,000,000 | 3,619,000,000 | -6,887,000,000 | 1,463,000,000 |
first quarter | |||||
proceeds from sale of business | 14,000,000 | 0 | 0 | ||
first nine months | |||||
equity method investment dividends received in excess of (earnings)/losses and impairments | 38,000,000 | ||||
1,702 | |||||
benefit from/(benefit from) credit and insurance losses | 89,000,000 | 116,000,000 | |||
net | 10,000,000 | 10,000,000 | -14,000,000 | ||
121 | |||||
held-for-sale impairment charges | 2,000,000 | ||||
brazil manufacturing exit non-cash charges | |||||
1 | |||||
benefit from deferred income taxes | -1,215,000,000 | -1,247,000,000 | |||
8 | |||||
held for sale impairment charges | |||||
pension and other post-retirement employee benefits | 1,481,000,000 | ||||
equity method investment dividends received in excess of | |||||
55 | |||||
equity investment dividends received in excess of (earnings)/losses | 21,000,000 | -2,000,000 | |||
net realized and unrealized (gains)/losses on cash equivalents, marketable securities, and other investments | |||||
increase/(decrease) in benefit from credit and insurance losses | |||||
net unrealized | |||||
principal payments on long-term debt | -9,873,000,000 | ||||
net (gain)/loss on changes in investments in affiliates | |||||
net income | |||||
equity investment (earnings)/losses in excess of dividends received | |||||
purchases of marketable and other securities | |||||
sales and maturities of marketable and other securities | |||||
cash dividends | |||||
cash, cash equivalents, and restricted cash at january 1 | |||||
cash, cash equivalents, and restricted cash at september 30 | |||||
cash, cash equivalents, and restricted cash at june 30 | |||||
purchases of equity and debt securities | |||||
sales and maturities of equity and debt securities | |||||
proceeds from issuance of other debt | |||||
principal payments on other debt | |||||
cash, cash equivalents, and restricted cash at march 31 | |||||
effect of exchange rate changes on cash and cash equivalents | |||||
net increase/(decrease) in cash and cash equivalents | |||||
cash and cash equivalents at january 1 | |||||
cash and cash equivalents at march 31 | |||||
cash flows from operating activities of continuing operations | |||||
cash flows from investing activities of continuing operations | |||||
capital expenditures | |||||
acquisitions of retail and other finance receivables and operating leases | |||||
collections of retail and other finance receivables and operating leases | |||||
purchases of securities | |||||
sales and maturities of securities | |||||
cash flows from financing activities of continuing operations | |||||
changes in short-term debt |
We provide you with 20 years of cash flow statements for Ford Motor stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Ford Motor stock. Explore the full financial landscape of Ford Motor stock with our expertly curated income statements.
The information provided in this report about Ford Motor stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.